| Basics |
|
Biodesix, Inc. Common Stock
|
| IPO Date: |
November 1, 2020 |
| Sector: |
Healthcare |
| Industry: |
Healthcare Providers and Services |
| Market Cap: |
$68.34M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 4.58%
|
| Avg Daily Range (30 D): |
$0.34 | 4.49%
|
| Avg Daily Range (90 D): |
$0.34 | 5.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.64M |
| Avg Daily Volume (30 D): |
2.18M |
| Avg Daily Volume (90 D): |
1.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
304 |
| Avg Trade Size (Sh.) (30 D): |
98 |
| Avg Trade Size (Sh.) (90 D): |
112 |
| Institutional Trades |
| Total Inst.Trades: |
40 |
| Avg Inst. Trade: |
$1.78M |
| Avg Inst. Trade (30 D): |
$1.35M |
| Avg Inst. Trade (90 D): |
$1.26M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.84M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
22.86K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-1.16
|
$-.08
|
|
Diluted EPS
|
|
$-1.16
|
$-.08
|
|
Revenue
|
$
|
$ 21.77M
|
$ 20.02M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -8.72M
|
$ -11.47M
|
|
Operating Income / Loss
|
$
|
$ -7.05M
|
$ -9.72M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ -4.12M
|
$ 3.13M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Sep 15, 2025:
1:20
|
|
|
|